Q Therapeutics, Inc. 3
3 · Q Therapeutics, Inc. · Filed Nov 23, 2015
Insider Transaction Report
Form 3
Q Therapeutics, Inc.[NONE]
Green David A
Chief Financial Officer
Holdings
Options to Purchase Common Stock
Exercise: $0.70From: 2016-06-30Exp: 2025-11-16→ Common Stock (100,000 underlying)Options to Purchase Common Stock
Exercise: $0.70From: 2016-11-10Exp: 2025-11-17→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]28% of the shares vest on November 10, 2016, date and 2% per month thereafter.
- [F2]Options would vest immediately upon closing an equity and/or debt financing in the cumulative amount of $15 million on or prior to June 30, 2016.